Resmed (RMD) Total Current Liabilities (2010 - 2026)

Resmed (RMD) has 17 years of Total Current Liabilities data on file, last reported at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 43.67% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 43.67% YoY), and the FY2025 full-year result was $1.0 billion, up 11.91% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $1.4 billion, up from $1.2 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $1.4 billion in Q1 2026 and bottomed at $667.3 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $773.0 million (2024), against an average of $887.7 million.
• The widest annual swing landed in 2022, when Total Current Liabilities fell 24.4%; it then jumped 46.5% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $732.7 million in 2022, then climbed by 4.28% to $764.1 million in 2023, then advanced by 11.5% to $852.0 million in 2024, then jumped by 46.5% to $1.2 billion in 2025, then gained by 8.26% to $1.4 billion in 2026.
• The last three Total Current Liabilities figures came in at $1.4 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison